Poland
  • Afghanistan
  • Åland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belau
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bonaire, Saint Eustatius and Saba
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo (Brazzaville)
  • Congo (Kinshasa)
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and McDonald Islands
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jersey
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • North Korea
  • North Macedonia
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palestinian Territory
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • São Tomé and Príncipe
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin (Dutch part)
  • Saint Martin (French part)
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia/Sandwich Islands
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Timor-Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom (UK)
  • United States (US)
  • United States (US) Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Venezuela
  • Vietnam
  • Virgin Islands (British)
  • Virgin Islands (US)
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
Change currency (GBP)
  • GBP
  • EUR
Nu Derma Supply logo

Nu Derma Supply

  • Change Location:
    Poland
    • Afghanistan
    • Åland Islands
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antarctica
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belau
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • Bhutan
    • Bolivia
    • Bonaire, Saint Eustatius and Saba
    • Bosnia and Herzegovina
    • Botswana
    • Bouvet Island
    • Brazil
    • British Indian Ocean Territory
    • Brunei
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo (Brazzaville)
    • Congo (Kinshasa)
    • Cook Islands
    • Costa Rica
    • Croatia
    • Cuba
    • Curaçao
    • Cyprus
    • Czech Republic
    • Denmark
    • Djibouti
    • Dominica
    • Dominican Republic
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Eswatini
    • Ethiopia
    • Falkland Islands
    • Faroe Islands
    • Fiji
    • Finland
    • France
    • French Guiana
    • French Polynesia
    • French Southern Territories
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guernsey
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Heard Island and McDonald Islands
    • Honduras
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Ireland
    • Isle of Man
    • Israel
    • Italy
    • Ivory Coast
    • Jamaica
    • Japan
    • Jersey
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • Kuwait
    • Kyrgyzstan
    • Laos
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macao
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Micronesia
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • North Korea
    • North Macedonia
    • Northern Mariana Islands
    • Norway
    • Oman
    • Pakistan
    • Palestinian Territory
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Reunion
    • Romania
    • Russia
    • Rwanda
    • São Tomé and Príncipe
    • Saint Barthélemy
    • Saint Helena
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Martin (Dutch part)
    • Saint Martin (French part)
    • Saint Pierre and Miquelon
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovakia
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • South Georgia/Sandwich Islands
    • South Korea
    • South Sudan
    • Spain
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard and Jan Mayen
    • Sweden
    • Switzerland
    • Syria
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Timor-Leste
    • Togo
    • Tokelau
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Turks and Caicos Islands
    • Tuvalu
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom (UK)
    • United States (US)
    • United States (US) Minor Outlying Islands
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican
    • Venezuela
    • Vietnam
    • Virgin Islands (British)
    • Virgin Islands (US)
    • Wallis and Futuna
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
  • Change Currency:
    GBP
    • GBP
    • EUR
  • Contact Us

Synvisc vs Synvisc One

To cater to an ever-expanding aging population, treatments to manage conditions that are prevalent in the elderly are increasing in number. Patients receiving these treatments should be knowledgeable about the different modalities and medications in order to determine the right treatment for their lifestyle and condition. Here, we compare Synvisc, a popular injection used in the treatment of knee osteoarthritis, with its single-dosing-regimen, Synvisc One, in terms of their respective benefits and drawbacks.

Osteoarthritis of the knee

Patients who complain about joint stiffness, pain, and swelling may be suffering from a form of arthritis that affects the bone called osteoarthritis. With this condition, the damage inflicted by the wear and tear that affects weight-bearing joints, such as the knees, is accelerated due to the degradation of protective cartilage at the ends of the bones. These effects lead to the development of inflammation in joints and the subsequent disease state.
This condition, if severe, can be debilitating, as the pain and swelling makes it hard for the patient to perform activities like walking, playing sports, or exercising. Mobility may also be restricted, which can have a negative impact on the patient’s quality of life. This condition predominantly affects the aging, the obese, and those with a prior injury to the knee.
This condition is progressive and has no known cure. However, certain types of medical therapies are available that can help the patient to relive symptoms of osteoarthritis and slow down or prevent the further progression of this degenerative condition. Such therapies include taking analgesics, such as acetaminophen; anti-inflammatory medications, including injections of cortisone to the knee; undergoing physical therapy to strengthen the muscles surrounding the knee; and/or undergoing weight loss management that can help to decrease stress on the knee.

The role of viscosupplements in the treatment of osteoarthritis

Hyaluronic acid injections are a common type of treatment given to patients who have not responded adequately to the standard therapies used to treat osteoarthritis, which include the therapies mentioned above. They are classed as viscosupplements because they are administered as a means of restoring the normal rheological environment in the joint so as to re-establish the lubrication and cushioning effects that are often lost with the development of osteoarthritis. The benefits of viscosupplements have been well-documented, and its effects having been shown to last for several months. There are multiple types of viscosupplementation products, each with its own composition, duration of effect, and recommended dosing regimens.
Synvisc and Synvisc One are two such viscosupplements. They are unique from other viscosupplements in that they are primarily composed of hylan, a high-molecular-weight, cross-linked derivative of hyaluronic acid. The primary compound is one that is cross-linked and made up of two types of hylan: hylan A and hylan B. Hylan A is a 6000kDa soluble molecule that makes up 80% of the compound in terms of volume. Hylan B is an insoluble gel-like molecular network that makes up 20% of the compound in terms of volume. In Synvisc and Synvisc One, these hylan compounds are contained in a buffered physiological sodium chloride solution. Synvisc and Synvisc One have greater viscoelastic properties than natural hyaluronic acid, and their properties are comparable to that of healthy human synovial fluid.

Who should not use Synvisc and Synvisc One?

Synvisc and Synvisc One are indicated for the treatment of knee osteoarthritis in patients that have failed to adequately respond to the condition’s conventional therapies, such as pain medications and physical therapy. Patients who are not good candidates to receive Synvisc or Synvisc One treatments are those with a known hypersensitivity (allergy) to hyaluronan (sodium hyaluronate) preparations and/or avian proteins, feathers, and egg products, since Synvisc and Synvisc One are derived from chicken/rooster combs, which are obviously avian sources. As with any intraarticular injection, following sterile precautions is crucial to preventing the occurrence of septic arthritis. Hence, Synvisc and Synvisc-One should not be injected in the knees of patients that have skin diseases, knee joint infections, and/or infections in the area of the injection site.

How do Synvisc and Synvisc One differ from each other?

Synvisc is exactly the same as Synvisc One. They only differ in terms of their respective dose regimen. While Synvisc is administered in a series of three weekly sessions consisting of 2ml injections, Synvisc One is a combination of the three Synvisc doses given in a single 6ml injection. Both have similar efficacy profiles, and both are comparable in terms of safety and tolerability. Both treatments can be safely repeated.
There are several benefits to having a single-dose regimen as opposed to a multi-dose regimen. To start, with every added injection, the risk for contracting an infection or other local adverse reactions increases. A single-dose regimen negates that risk, as it decreases the need to repeatedly disturb the sterile intra-articular environment. Hence, a single-dose regimen can potentially decrease the risk of septic arthritis and other local comorbidities occurring.
In addition, a single-dose regimen also means fewer visits to the doctor. This will, in turn, allow for better patient compliance, improved convenience, and lower medical expenses, as the patient will not have to pay for additional visits.

Conclusion

Synvisc and Synvisc One are treatments used in managing knee osteoarthritis, and they are effective in improving the condition’s symptoms, such as joint pain and swelling. Synvisc and Synvisc One differ only in terms of their respective dosing regimen. The benefits to be gained by following a single-dose regimen, which include increased convenience and a lower medical cost, may compel patients to pursue Synvisc One.

Continue reading

Belotero Filler Side Effects

Understanding Potential Belotero Filler Side Effects: Safety Considerations

Did you know that, according to the American Board of Cosmetic Surgery, over a million men and women choose dermal fillers annually? The common reasons are to fill in sunken areas of the face and to get rid of wrinkles.  Due to the popularity of…

Read More
belotero skin booster

How Belotero Skin Booster Stands Out From Other Dermal Fillers

Did you know that dermal fillers can also be skincare nowadays? Modern advancement has given way to include higher quality products in dermal fillers, making them function as skincare as well as being an aesthetic treatment. Dermal fillers are steadily on the rise these days due to being less invasive…

Read More
Belotero filler types

Belotero Filler Types: A Comprehensive Overview

According to an article by the University of Utah’s Health Department, skin aging like facial wrinkles and volume loss can start in the mid-20s to early 30s. Factors other than aging can include sun exposure, environment, diet, and genetics. The body also gradually decreases the…

Read More
Our website is intended solely for people who use medical devices, such as dermal fillers, as professionals. It may contain product advertisements targeted only at such people. To enter Nu Derma Supply, please confirm that you are such a person (e.g. a medical professional, cosmetologist, service technician, etc.).
Decline